ロード中...
Topical rapamycin (sirolimus) for facial angiofibromas
Rapamycin (sirolimus) is a fungal fermentation product that inhibits the proper functioning of a serine/threonine protein kinase in mammalian cells eponymously named mammalian target of rapamycin, or mTOR. Rapamycin is a novel class of anticancer and immunosuppressant drugs targeting the proteins at...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573457/ https://ncbi.nlm.nih.gov/pubmed/23439391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.105488 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|